Low-grade inflammation, obesity, and insulin resistance in adolescents

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 12, 2007, Pages 4569-4574

  Herder, Christian ^a,c   Schneitler, Sophie ^a   Rathmann, Wolfgang ^a   Haastert, Burkhard ^a   Schneitler, Heiko ^b   Winkler, Horst ^b   Bredahl, Renate ^b   Hahnloser, Erik ^b   Martin, Stephan ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Gesundheitsamt (Public Health Office)   (Germany)

^c LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INSULIN; INTERLEUKIN 18; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; AGE; ARTICLE; BODY MASS; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GERMANY; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

EID: 36849013098     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-0955     Document Type: Article

References (42)

1. Kolb H, Mandrup-Poulsen T 2005 An immune origin of type 2 diabetes? Diabetologia 48:1038-1050
2. Pickup JC 2004 Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27:813-823
3. Kershaw EE, Flier JS 2004 Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556
4. Kahn SE, Hull RL, Utzschneider KM 2006 Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840-846
5. Skurk T, Herder C, Kraft I, Muller-Scholze S, Hauner H, Kolb H 2005 Production and release of macrophage migration inhibitory factor from human adipocytes. Endocrinology 146:1006-1011
6. Skurk T, Kolb H, Muller-Scholze S, Rohrig K, Hauner H, Herder C 2005 The proatherogenic cytokine interleukin-18 is secreted by human adipocytes. Eur J Endocrinol 152:863-868
7. Herder C, Hauner H, Kempf K, Kolb H, Skurk T 2007 Constitutive and regulated expression and secretion of interferon-γ inducible protein 10 (IP-10/CXCL10) in human adipocytes. Int J Obes (Lond) 31:403-410
8. Cook DG, Mendall MA, Whincup PH, Carey IM, Ballam L, Morris JE, Miller GJ, Strachan DP 2000 C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 149:139-150
9. Ford ES, Galuska DA, Gillespie C, Will JC, Giles WH, Dietz WH 2001 C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Pediatr 138:486-492
10. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB 2001 Low-grade systemic inflammation in overweight children. Pediatrics 107:E13
11. Hiura M, Kikuchi T, Nagasaki K, Uchiyama M 2003 Elevation of serum C-reactive protein levels is associated with obesity in boys. Hypertens Res 26:541-546
12. Gillum RF 2003 Association of serum C-reactive protein and indices of body fat distribution and overweight in Mexican American children. J Natl Med Assoc 95:545-552
13. Mangge H, Schauenstein K, Stroedter L, Griesl A, Maerz W, Borkenstein M 2004 Low grade inflammation in juvenile obesity and type 1 diabetes associated with early signs of atherosclerosis. Exp Clin Endocrinol Diabetes 112:378-382
14. Lambert M, Delvin EE, Paradis G, O'Loughlin J, Hanley JA, Levy E 2004 C-reactive protein and features of the metabolic syndrome in a population-based sample of children and adolescents. Clin Chem 50:1762-1768
15. Ford ES, Ajani UA, Mokdad AH 2005 The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care 28:878-881
16. Reinehr T, Stoffel-Wagner B, Roth CL, Andler W 2005 High-sensitive C-reactive protein, tumor necrosis factor α, and cardiovascular risk factors before and after weight loss in obese children. Metabolism 54:1155-1161
17. de Ferranti SD, Gauvreau K, Ludwig DS, Newburger JW, Rifai N 2006 Inflammation and changes in metabolic syndrome abnormalities in U.S. adolescents: findings from the 1988-1994 and 1999-2000 National Health and Nutrition Examination Surveys. Clin Chem 52:1325-1330
18. Platat C, Wagner A, Klumpp T, Schweitzer B, Simon C 2006 Relationships of physical activity with metabolic syndrome features and low-grade inflammation in adolescents. Diabetologia 49:2078-2085
19. Wu DM, Chu NF, Shen MH, Wang SC 2006 Obesity, plasma high sensitivity C-reactive protein levels and insulin resistance status among school children in Taiwan. Clin Biochem 39:810-815
20. Yoshida T, Kaneshi T, Shimabukuro T, Sunagawa M, Ohta T 2006 Serum C-reactive protein and its relation to cardiovascular risk factors and adipocytokines in Japanese children. J Clin Endocrinol Metab 91:2133-2137
21. Kapiotis S, Holzer G, Schaller G, Haumer M, Widhalm H, Weghuber D, Jilma B, Roggla G, Wolzt M, Widhalm K, Wagner OF 2006 A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes. Arterioscler Thromb Vasc Biol 26:2541-2546
22. Herder C, Haastert B, Muller-Scholze S, Koenig W, Thorand B, Holle R, Wichmann HE, Scherbaum WA, Martin S, Kolb H 2005 Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). Diabetes 54(Suppl 2):S11-S17
23. Herder C, Hauner H, Haastert B, Rohrig K, Koenig W, Kolb H, Muller-Scholze S, Thorand B, Holle R, Rathmann W 2006 Hypoadiponectinemia and proinflammatory state: two sides of the same coin? Results from the Cooperative Health Research in the Region of Augsburg Survey 4 (KORA S4). Diabetes Care 29:1626-1631
24. Herder C, Kolb H, Koenig W, Haastert B, Muller-Scholze S, Rathmann W, Holle R, Thorand B, Wichmann HE 2006 Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4). Diabetes Care 29:368-371
25. Thorand B, Kolb H, Baumert J, Koenig W, Chambless L, Meisinger C, Illig T, Martin S, Herder C 2005 Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002. Diabetes 54:2932-2938
26. Herder C, Baumert J, Thorand B, Koenig W, de Jager W, Meisinger C, Illig T, Martin S, Kolb H 2006 Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002. Diabetologia 49:921-929
27. Yeste D, Vendrell J, Tomasini R, Broch M, Gussinyé M, Megia A, Carracosa A 2007 Interleukin-6 in obese children and adolescents with and without glucose intolerance. Diabetes Care 30:1892-1894
28. Moon YS, Kim DH, Song DK 2004 Serum tumor necrosis factor-α levels and components of the metabolic syndrome in obese adolescents. Metabolism 53:863-867
29. Gupta A, Ten S, Anhalt H 2005 Serum levels of tumor necrosis factor-α receptor 2 are linked to insulin resistance and glucose intolerance in children. J Pediatr Endocrinol Metab 18:75-82
30. Balagopal P, George D, Yarandi H, Funanage V, Bayne E 2005 Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: a controlled, randomized study in obese adolescents. J Clin Endocrinol Metab 90:6192-6197
31. Winer JC, Zern TL, Taksali SE, Dziura J, Cali AMG, Wollschlager M, Seyal AA, Weiss R, Burgert TS, Caprio S 2006 Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. J Clin Endocrinol Metab 91:4415-4423
32. Araki S, Dobashi K, Kubo K, Asayama K, Shirahata A 2006 High molecular weight, rather than total, adiponectin levels better reflect metabolic abnormalities associated with childhood obesity. J Clin Endocrinol Metab 91:5113-5116
33. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K 2003 Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 14:561-566
34. Chandran M, Phillips SA, Ciaraldi T, Henry RR 2003 Adiponectin: more than just another fat cell hormone? Diabetes Care 26:2442-2450
35. Herder C, Schmitz-Beuting C, Rathmann W, Haastert B, Schmitz-Beuting J, Schäfer M, Scherbaum WA, Schneitler H, Martin S 2007 Prevalence of impaired glucose regulation in German school-leaving students. Int J Obes (Lond) 31:1086-1088
36. Wellen KE, Hotamisligil GS 2003 Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112:1785-1788
37. Van Gaal LF, Mertens I, DeBlock CD 2006 Mechanisms linking obesity with cardiovascular disease. Nature 444:875-880
38. Kristiansen OP, Mandrup-Poulsen T 2005 Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes 54(Suppl 2):S114-S124
39. Conwell JS, Trost SG, Brown WJ, Batch JA 2004 Indexes of insulin resistance and secretion in obese children and adolescents: a validation study. Diabetes Care 27:314-319
40. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C 2005 Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 115:e500-e503
41. Gungor N, Saad R, Janosky J, Arslanian S 2004 Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr 144:47-55
42. Yeckel CW, Weiss R, Dziura J, Taksali SE, Dufour S, Burgert TS, Tamborlane WV, Caprio S 2004 Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab 89:1096-1101